The hyperfunction theory of aging: three common misconceptions
Oncoscience · 2021-09-17 · 8 · 103-107
DOI: 10.18632/oncoscience.545 ↗At a glance
Editorial in Oncoscience, published on 2021-09-17. Written by Mikhail V Blagosklonny. Institution: Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Cited 36 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Almost all papers on aging start with the statement that aging is functional decline caused by accumulation of molecular damage. In contrast, according to the hyperfunction theory, aging is not functional decline, but results from cellular hyperfunctions that produce agerelated diseases. The sum of these age-related diseases is aging (Figure 1). Functional decline is secondary to primary hyperfunctions. Second, aging is not caused by the accumulation of molecular damage—it is caused by inappropriate activation of signaling pathways, such as mTOR. These signaling pathways directly drive agerelated diseases. The hyperfunction theory of aging was discussed in detail in numerous papers (just to name a few [1–10]). However, given the unconventional nature of the hyperfunction theory, some points are commonly misunderstood. Here, I will address three common misconceptions people tend to have about the hyperfunction theory, without discussing the theory in detail. MISCONCEPTION 1
Subjects
Author keywords
Authors and institutions
- Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Cite
APA
Blagosklonny, M. V. (2021). The hyperfunction theory of aging: three common misconceptions. Oncoscience, 8, 103-107. https://doi.org/10.18632/oncoscience.545
Vancouver
Blagosklonny MV. The hyperfunction theory of aging: three common misconceptions. Oncoscience. 2021;8:103-107. doi:10.18632/oncoscience.545
BibTeX
@article{Blagosklonny2021,
author = {Blagosklonny, Mikhail V},
title = {The hyperfunction theory of aging: three common misconceptions},
journal = {Oncoscience},
year = {2021},
volume = {8},
pages = {103--107},
doi = {10.18632/oncoscience.545}
}
EUVIMED